A clinically viable approach to restoring visual function using optogenetic gene therapy

A clinically viable approach to restoring visual function using optogenetic gene therapy

Optogenetic gene therapies offer a promising strategy for restoring vision to patients with retinal degenerative diseases, such as retinitis pigmentosa (RP). Several clinical trials have begun in this area using different vectors and optogenetic proteins (Clinical Identifiers: NCT02556736, NCT033263...

Full description

Bibliographic Details
Main Authors: Boyuan Yan, Suresh Viswanathan, Scott E. Brodie, Wen-Tao Deng, Kirsten E. Coleman, William W. Hauswirth, Sheila Nirenberg
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
optogenetic gene therapy
retinal prosthesis
preclinical study
retinitis pigmentosa
vision restoration
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050123000670

Internet

http://www.sciencedirect.com/science/article/pii/S2329050123000670

Similar Items